ID FCGBP_HUMAN Reviewed; 5405 AA. AC Q9Y6R7; O95784; DT 31-OCT-2006, integrated into UniProtKB/Swiss-Prot. DT 03-MAR-2009, sequence version 3. DT 27-MAR-2024, entry version 158. DE RecName: Full=IgGFc-binding protein; DE AltName: Full=Fcgamma-binding protein antigen; DE Short=FcgammaBP; DE Flags: Precursor; GN Name=FCGBP; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], VARIANTS ALA-2814; SER-4465; HIS-4906 AND RP VAL-5017, FUNCTION, INTERACTION WITH IGG, AND TISSUE SPECIFICITY. RC TISSUE=Colon epithelium; RX PubMed=9182547; DOI=10.1074/jbc.272.24.15232; RA Harada N., Iijima S., Kobayashi K., Yoshida T., Brown W.R., Hibi T., RA Oshima A., Morikawa M.; RT "Human IgGFc binding protein (FcgammaBP) in colonic epithelial cells RT exhibits mucin-like structure."; RL J. Biol. Chem. 272:15232-15241(1997). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15057824; DOI=10.1038/nature02399; RA Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E., RA Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A., RA Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S., RA Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A., RA Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J., RA Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M., RA Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W., RA Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V., RA Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D., RA McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I., RA Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L., RA Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A., RA She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M., RA Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J., RA Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E., RA Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M., RA Rubin E.M., Lucas S.M.; RT "The DNA sequence and biology of human chromosome 19."; RL Nature 428:529-535(2004). RN [3] RP TISSUE SPECIFICITY. RX PubMed=11600203; DOI=10.1016/s0165-2478(01)00288-7; RA Kobayashi K., Yagasaki M., Harada N., Chichibu K., Hibi T., Yoshida T., RA Brown W.R., Morikawa M.; RT "Detection of Fcgamma binding protein antigen in human sera and its RT relation with autoimmune diseases."; RL Immunol. Lett. 79:229-235(2001). RN [4] RP TISSUE SPECIFICITY. RX PubMed=12208673; DOI=10.1677/joe.0.1740517; RA O'Donovan N., Fischer A., Abdo E.-M., Simon F., Peter H.J., Gerber H., RA Buergi U., Marti U.; RT "Differential expression of IgG Fc binding protein (FcgammaBP) in human RT normal thyroid tissue, thyroid adenomas and thyroid carcinomas."; RL J. Endocrinol. 174:517-524(2002). RN [5] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-3719. RC TISSUE=Bile; RX PubMed=15084671; DOI=10.1074/mcp.m400015-mcp200; RA Kristiansen T.Z., Bunkenborg J., Gronborg M., Molina H., Thuluvath P.J., RA Argani P., Goggins M.G., Maitra A., Pandey A.; RT "A proteomic analysis of human bile."; RL Mol. Cell. Proteomics 3:715-728(2004). RN [6] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-75; ASN-91; ASN-1743; ASN-2138 RP AND ASN-2518. RC TISSUE=Plasma; RX PubMed=16335952; DOI=10.1021/pr0502065; RA Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., RA Smith R.D.; RT "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, RT hydrazide chemistry, and mass spectrometry."; RL J. Proteome Res. 4:2070-2080(2005). RN [7] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-2518. RC TISSUE=Saliva; RX PubMed=16740002; DOI=10.1021/pr050492k; RA Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong D.T., Loo J.A.; RT "Identification of N-linked glycoproteins in human saliva by glycoprotein RT capture and mass spectrometry."; RL J. Proteome Res. 5:1493-1503(2006). RN [8] RP INTERACTION WITH MUC2. RX PubMed=19432394; DOI=10.1021/pr9002504; RA Johansson M.E.V., Thomsson K.A., Hansson G.C.; RT "Proteomic analyses of the two mucus layers of the colon barrier reveal RT that their main component, the Muc2 mucin, is strongly bound to the Fcgbp RT protein."; RL J. Proteome Res. 8:3549-3557(2009). RN [9] RP GLYCOSYLATION AT ASN-1317. RX PubMed=19139490; DOI=10.1074/mcp.m800504-mcp200; RA Jia W., Lu Z., Fu Y., Wang H.P., Wang L.H., Chi H., Yuan Z.F., Zheng Z.B., RA Song L.N., Han H.H., Liang Y.M., Wang J.L., Cai Y., Zhang Y.K., Deng Y.L., RA Ying W.T., He S.M., Qian X.H.; RT "A strategy for precise and large scale identification of core fucosylated RT glycoproteins."; RL Mol. Cell. Proteomics 8:913-923(2009). CC -!- FUNCTION: May be involved in the maintenance of the mucosal structure CC as a gel-like component of the mucosa. {ECO:0000269|PubMed:9182547}. CC -!- SUBUNIT: Interacts with the Fc portion of IgG and with MUC2. CC {ECO:0000269|PubMed:19432394, ECO:0000269|PubMed:9182547}. CC -!- INTERACTION: CC Q9Y6R7; Q07654: TFF3; NbExp=2; IntAct=EBI-2869882, EBI-10224676; CC -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}. CC -!- TISSUE SPECIFICITY: Mainly expressed in placenta and colon epithelium. CC Expressed in thyroid, and down-regulated in thyroid carcinomas. Present CC in serum, with higher levels in patients with various autoimmune CC diseases (at protein level). {ECO:0000269|PubMed:11600203, CC ECO:0000269|PubMed:12208673, ECO:0000269|PubMed:9182547}. CC -!- DOMAIN: The N-terminal IgGFc-binding region is primate-specific. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; D84239; BAA19526.1; -; mRNA. DR EMBL; AC006950; AAD15624.1; -; Genomic_DNA. DR EMBL; AC007842; AAD39266.1; -; Genomic_DNA. DR EMBL; AC011536; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR RefSeq; NP_003881.2; NM_003890.2. DR SMR; Q9Y6R7; -. DR BioGRID; 114381; 18. DR IntAct; Q9Y6R7; 8. DR STRING; 9606.ENSP00000481056; -. DR MEROPS; I08.954; -. DR GlyConnect; 1386; 21 N-Linked glycans (10 sites). DR GlyCosmos; Q9Y6R7; 18 sites, 28 glycans. DR GlyGen; Q9Y6R7; 18 sites, 27 N-linked glycans (10 sites), 1 O-linked glycan (3 sites). DR iPTMnet; Q9Y6R7; -. DR PhosphoSitePlus; Q9Y6R7; -. DR BioMuta; FCGBP; -. DR DMDM; 224471888; -. DR CPTAC; non-CPTAC-1133; -. DR EPD; Q9Y6R7; -. DR jPOST; Q9Y6R7; -. DR MassIVE; Q9Y6R7; -. DR MaxQB; Q9Y6R7; -. DR PeptideAtlas; Q9Y6R7; -. DR ProteomicsDB; 86780; -. DR DNASU; 8857; -. DR Ensembl; ENST00000628705.2; ENSP00000487490.3; ENSG00000281123.4. DR GeneID; 8857; -. DR KEGG; hsa:8857; -. DR MANE-Select; ENST00000628705.3; ENSP00000487490.3; NM_003890.3; NP_003881.2. DR AGR; HGNC:13572; -. DR CTD; 8857; -. DR DisGeNET; 8857; -. DR GeneCards; FCGBP; -. DR HGNC; HGNC:13572; FCGBP. DR MIM; 617553; gene. DR neXtProt; NX_Q9Y6R7; -. DR PharmGKB; PA28059; -. DR InParanoid; Q9Y6R7; -. DR OrthoDB; 2872912at2759; -. DR PhylomeDB; Q9Y6R7; -. DR TreeFam; TF316399; -. DR PathwayCommons; Q9Y6R7; -. DR SignaLink; Q9Y6R7; -. DR BioGRID-ORCS; 8857; 16 hits in 1055 CRISPR screens. DR ChiTaRS; FCGBP; human. DR GeneWiki; FCGBP; -. DR GenomeRNAi; 8857; -. DR Pharos; Q9Y6R7; Tbio. DR PRO; PR:Q9Y6R7; -. DR Proteomes; UP000005640; Unplaced. DR RNAct; Q9Y6R7; Protein. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0031012; C:extracellular matrix; IBA:GO_Central. DR GO; GO:0005615; C:extracellular space; IBA:GO_Central. DR CDD; cd19941; TIL; 12. DR Gene3D; 2.10.25.10; Laminin; 12. DR InterPro; IPR000742; EGF-like_dom. DR InterPro; IPR003645; Fol_N. DR InterPro; IPR035234; IgGFc-bd_N. DR InterPro; IPR036084; Ser_inhib-like_sf. DR InterPro; IPR002919; TIL_dom. DR InterPro; IPR025615; TILa_dom. DR InterPro; IPR014853; VWF/SSPO/ZAN-like_Cys-rich_dom. DR InterPro; IPR001007; VWF_dom. DR InterPro; IPR001846; VWF_type-D. DR PANTHER; PTHR11339; EXTRACELLULAR MATRIX GLYCOPROTEIN RELATED; 1. DR PANTHER; PTHR11339:SF244; IGGFC-BINDING PROTEIN; 1. DR Pfam; PF08742; C8; 12. DR Pfam; PF17517; IgGFc_binding; 1. DR Pfam; PF01826; TIL; 12. DR Pfam; PF12714; TILa; 11. DR Pfam; PF00094; VWD; 13. DR SMART; SM00832; C8; 12. DR SMART; SM00181; EGF; 7. DR SMART; SM00274; FOLN; 9. DR SMART; SM00214; VWC; 7. DR SMART; SM00215; VWC_out; 11. DR SMART; SM00216; VWD; 13. DR SUPFAM; SSF57567; Serine protease inhibitors; 12. DR PROSITE; PS51233; VWFD; 13. PE 1: Evidence at protein level; KW Disulfide bond; Glycoprotein; Reference proteome; Repeat; Secreted; Signal. FT SIGNAL 1..23 FT /evidence="ECO:0000255" FT CHAIN 24..5405 FT /note="IgGFc-binding protein" FT /id="PRO_0000256698" FT DOMAIN 470..650 FT /note="VWFD 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 745..799 FT /note="TIL 1" FT DOMAIN 862..1041 FT /note="VWFD 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 1136..1189 FT /note="TIL 2" FT DOMAIN 1250..1429 FT /note="VWFD 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 1532..1585 FT /note="TIL 3" FT DOMAIN 1671..1854 FT /note="VWFD 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 1950..2007 FT /note="TIL 4" FT DOMAIN 2070..2253 FT /note="VWFD 5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 2337..2390 FT /note="TIL 5" FT DOMAIN 2451..2630 FT /note="VWFD 6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 2733..2786 FT /note="TIL 6" FT DOMAIN 2872..3055 FT /note="VWFD 7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 3151..3208 FT /note="TIL 7" FT DOMAIN 3271..3454 FT /note="VWFD 8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 3538..3591 FT /note="TIL 8" FT DOMAIN 3652..3831 FT /note="VWFD 9" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 3934..3987 FT /note="TIL 9" FT DOMAIN 4073..4256 FT /note="VWFD 10" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 4352..4409 FT /note="TIL 10" FT DOMAIN 4472..4655 FT /note="VWFD 11" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 4739..4792 FT /note="TIL 11" FT DOMAIN 4854..5025 FT /note="VWFD 12" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DOMAIN 5121..5174 FT /note="TIL 12" FT DOMAIN 5233..5404 FT /note="VWFD 13" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT REGION 24..450 FT /note="IgGFc-binding" FT CARBOHYD 75 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16335952" FT CARBOHYD 91 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16335952" FT CARBOHYD 1317 FT /note="N-linked (GlcNAc...) (complex) asparagine" FT /evidence="ECO:0000269|PubMed:19139490" FT CARBOHYD 1743 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16335952" FT CARBOHYD 2138 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16335952" FT CARBOHYD 2518 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16335952, FT ECO:0000269|PubMed:16740002" FT CARBOHYD 3719 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:15084671" FT CARBOHYD 4145 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 4540 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 472..611 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 494..649 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 864..1003 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 886..1040 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 1252..1390 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 1274..1428 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 1673..1815 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 1695..1853 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 1704..1812 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 2072..2211 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 2094..2252 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 2453..2591 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 2475..2629 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 2874..3016 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 2896..3054 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 2905..3013 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 3273..3412 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 3295..3453 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 3654..3792 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 3676..3830 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 4075..4217 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 4097..4255 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 4106..4214 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 4474..4613 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 4496..4654 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 4856..4986 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 4878..5024 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT DISULFID 5235..5372 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00580" FT VARIANT 732 FT /note="V -> A (in dbSNP:rs34181317)" FT /id="VAR_054490" FT VARIANT 770 FT /note="N -> S (in dbSNP:rs34939346)" FT /id="VAR_054491" FT VARIANT 929 FT /note="G -> R (in dbSNP:rs35338934)" FT /id="VAR_054492" FT VARIANT 971 FT /note="V -> M (in dbSNP:rs35922811)" FT /id="VAR_054493" FT VARIANT 1019 FT /note="G -> R (in dbSNP:rs34254649)" FT /id="VAR_054494" FT VARIANT 1340 FT /note="V -> L (in dbSNP:rs11083543)" FT /id="VAR_028903" FT VARIANT 1436 FT /note="P -> L (in dbSNP:rs36106401)" FT /id="VAR_054495" FT VARIANT 1445 FT /note="H -> D (in dbSNP:rs2909229)" FT /id="VAR_054496" FT VARIANT 1524 FT /note="T -> N (in dbSNP:rs34938990)" FT /id="VAR_054497" FT VARIANT 1616 FT /note="G -> V (in dbSNP:rs7248839)" FT /id="VAR_028904" FT VARIANT 1617 FT /note="M -> V (in dbSNP:rs7249743)" FT /id="VAR_028905" FT VARIANT 2089 FT /note="N -> D (in dbSNP:rs885723)" FT /id="VAR_028906" FT VARIANT 2646 FT /note="E -> D (in dbSNP:rs140171218)" FT /id="VAR_028907" FT VARIANT 2647 FT /note="E -> K (in dbSNP:rs1176978283)" FT /id="VAR_028908" FT VARIANT 2793 FT /note="A -> V (in dbSNP:rs2542316)" FT /id="VAR_028909" FT VARIANT 2814 FT /note="V -> A (in dbSNP:rs3746009)" FT /evidence="ECO:0000269|PubMed:9182547" FT /id="VAR_028910" FT VARIANT 3264 FT /note="G -> S (in dbSNP:rs1290971390)" FT /id="VAR_028911" FT VARIANT 3920 FT /note="H -> Q (in dbSNP:rs2542318)" FT /id="VAR_028912" FT VARIANT 4015 FT /note="V -> A (in dbSNP:rs3746009)" FT /id="VAR_028913" FT VARIANT 4095 FT /note="G -> D (in dbSNP:rs1975181)" FT /id="VAR_028914" FT VARIANT 4465 FT /note="G -> S (in dbSNP:rs6508919)" FT /evidence="ECO:0000269|PubMed:9182547" FT /id="VAR_028915" FT VARIANT 4906 FT /note="D -> H (in dbSNP:rs3746013)" FT /evidence="ECO:0000269|PubMed:9182547" FT /id="VAR_028916" FT VARIANT 5017 FT /note="A -> V (in dbSNP:rs741143)" FT /evidence="ECO:0000269|PubMed:9182547" FT /id="VAR_054498" FT CONFLICT 1961 FT /note="S -> P (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" FT CONFLICT 2719 FT /note="Q -> H (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" FT CONFLICT 2842 FT /note="N -> T (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" FT CONFLICT 2976 FT /note="T -> A (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" FT CONFLICT 3117 FT /note="R -> H (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" FT CONFLICT 3668 FT /note="H -> R (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" FT CONFLICT 3841 FT /note="A -> E (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" FT CONFLICT 3847..3848 FT /note="DK -> EE (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" FT CONFLICT 4043 FT /note="T -> N (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" FT CONFLICT 4284 FT /note="S -> A (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" FT CONFLICT 4318 FT /note="R -> H (in Ref. 1; BAA19526)" FT /evidence="ECO:0000305" SQ SEQUENCE 5405 AA; 572017 MW; 6E502F782261355F CRC64; MGALWSWWIL WAGATLLWGL TQEASVDLKN TGREEFLTAF LQNYQLAYSK AYPRLLISSL SESPASVSIL SQADNTSKKV TVRPGESVMV NISAKAEMIG SKIFQHAVVI HSDYAISVQA LNAKPDTAEL TLLRPIQALG TEYFVLTPPG TSARNVKEFA VVAGAAGASV SVTLKGSVTF NGKFYPAGDV LRVTLQPYNV AQLQSSVDLS GSKVTASSPV AVLSGHSCAQ KHTTCNHVVE QLLPTSAWGT HYVVPTLASQ SRYDLAFVVA SQATKLTYNH GGITGSRGLQ AGDVVEFEVR PSWPLYLSAN VGIQVLLFGT GAIRNEVTYD PYLVLIPDVA AYCPAYVVKS VPGCEGVALV VAQTKAISGL TIDGHAVGAK LTWEAVPGSE FSYAEVELGT ADMIHTAEAT TNLGLLTFGL AKAIGYATAA DCGRTVLSPV EPSCEGMQCA AGQRCQVVGG KAGCVAESTA VCRAQGDPHY TTFDGRRYDM MGTCSYTMVE LCSEDDTLPA FSVEAKNEHR GSRRVSYVGL VTVRAYSHSV SLTRGEVGFV LVDNQRSRLP VSLSEGRLRV YQSGPRAVVE LVFGLVVTYD WDCQLALSLP ARFQDQVCGL CGNYNGDPAD DFLTPDGALA PDAVEFASSW KLDDGDYLCE DGCQNNCPAC TPGQAQHYEG DRLCGMLTKL DGPFAVCHDT LDPRPFLEQC VYDLCVVGGE RLSLCRGLSA YAQACLELGI SVGDWRSPAN CPLSCPANSR YELCGPACPT SCNGAAAPSN CSGRPCVEGC VCLPGFVASG GACVPASSCG CTFQGLQLAP GQEVWADELC QRRCTCNGAT HQVTCRDKQS CPAGERCSVQ NGLLGCYPDR FGTCQGSGDP HYVSFDGRRF DFMGTCTYLL VGSCGQNAAL PAFRVLVENE HRGSQTVSYT RAVRVEARGV KVAVRREYPG QVLVDDVLQY LPFQAADGQV QVFRQGRDAV VRTDFGLTVT YDWNARVTAK VPSSYAEALC GLCGNFNGDP ADDLALRGGG QAANALAFGN SWQEETRPGC GATEPGDCPK LDSLVAQQLQ SKNECGILAD PKGPFRECHS KLDPQGAVRD CVYDRCLLPG QSGPLCDALA TYAAACQAAG ATVHPWRSEE LCPLSCPPHS HYEACSYGCP LSCGDLPVPG GCGSECHEGC VCDEGFALSG ESCLPLASCG CVHQGTYHPP GQTFYPGPGC DSLCHCQEGG LVSCESSSCG PHEACQPSGG SLGCVAVGSS TCQASGDPHY TTFDGRRFDF MGTCVYVLAQ TCGTRPGLHR FAVLQENVAW GNGRVSVTRV ITVQVANFTL RLEQRQWKVT VNGVDMKLPV VLANGQIRAS QHGSDVVIET DFGLRVAYDL VYYVRVTVPG NYYQQMCGLC GNYNGDPKDD FQKPNGSQAG NANEFGNSWE EVVPDSPCLP PTPCPPGSED CIPSHKCPPE LEKKYQKEEF CGLLSSPTGP LSSCHKLVDP QGPLKDCIFD LCLGGGNLSI LCSNIHAYVS ACQAAGGHVE PWRTETFCPM ECPPNSHYEL CADTCSLGCS ALSAPPQCQD GCAEGCQCDS GFLYNGQACV PIQQCGCYHN GVYYEPEQTV LIDNCRQQCT CHAGKGMVCQ EHSCKPGQVC QPSGGILSCV TKDPCHGVTC RPQETCKEQG GQGVCLPNYE ATCWLWGDPH YHSFDGRKFD FQGTCNYVLA TTGCPGVSTQ GLTPFTVTTK NQNRGNPAVS YVRVVTVAAL GTNISIHKDE IGKVRVNGVL TALPVSVADG RISVTQGASK ALLVADFGLQ VSYDWNWRVD VTLPSSYHGA VCGLCGNMDR NPNNDQVFPN GTLAPSIPIW GGSWRAPGWD PLCWDECRGS CPTCPEDRLE QYEGPGFCGP LAPGTGGPFT TCHAHVPPES FFKGCVLDVC MGGGDRDILC KALASYVAAC QAAGVVIEDW RAQVGCEITC PENSHYEVCG SPCPASCPSP APLTTPAVCE GPCVEGCQCD AGFVLSADRC VPLNNGCGCW ANGTYHEAGS EFWADGTCSQ WCRCGPGGGS LVCTPASCGL GEVCGLLPSG QHGCQPVSTA ECQAWGDPHY VTLDGHRFNF QGTCEYLLSA PCHGPPLGAE NFTVTVANEH RGSQAVSYTR SVTLQIYNHS LTLSARWPRK LQVDGVFVTL PFQLDSLLHA HLSGADVVVT TTSGLSLAFD GDSFVRLRVP AAYAGSLCGL CGNYNQDPAD DLKAVGGKPA GWQVGGAQGC GECVSKPCPS PCTPEQQESF GGPDACGVIS ATDGPLAPCH GLVPPAQYFQ GCLLDACQVQ GHPGGLCPAV ATYVAACQAA GAQLREWRRP DFCPFQCPAH SHYELCGDSC PGSCPSLSAP EGCESACREG CVCDAGFVLS GDTCVPVGQC GCLHDDRYYP LGQTFYPGPG CDSLCRCREG GEVSCEPSSC GPHETCRPSG GSLGCVAVGS TTCQASGDPH YTTFDGRRFD FMGTCVYVLA QTCGTRPGLH RFAVLQENVA WGNGRVSVTR VITVQVANFT LRLEQRQWKV TVNGVDMKLP VVLANGQIRA SQHGSDVVIE TDFGLRVAYD LVYYVRVTVP GNYYQLMCGL CGNYNGDPKD DFQKPNGSQA GNANEFGNSW EEVVPDSPCL PPPTCPPGSE GCIPSEECPP ELEKKYQKEE FCGLLSSPTG PLSSCHKLVD PQGPLKDCIF DLCLGGGNLS ILCSNIHAYV SACQAAGGQV EPWRNETFCP MECPQNSHYE LCADTCSLGC SALSAPLQCP DGCAEGCQCD SGFLYNGQAC VPIQQCGCYH NGAYYEPEQT VLIDNCRQQC TCHVGKVVVC QEHSCKPGQV CQPSGGILSC VNKDPCHGVT CRPQETCKEQ GGQGVCLPNY EATCWLWGDP HYHSFDGRKF DFQGTCNYVL ATTGCPGVST QGLTPFTVTT KNQNRGNPAV SYVRVVTVAA LGTNISIHKD EIGKVRVNGV LTALPVSVAD GRISVTQGAS KALLVADFGL QVSYDWNWRV DVTLPSSYHG AVCGLCGNMD RNPNNDQVFP NGTLAPSIPI WGGSWRAPGW DPLCWDECRG SCPTCPEDRL EQYEGPGFCG PLAPGTGGPF TTCHAHVPPE SFFKGCVLDV CMGGGDRDIL CKALASYVAA CQAAGVVIED WRAQVGCEIT CPENSHYEVC GPPCPASCPS PAPLTTPAVC EGPCVEGCQC DAGFVLSADR CVPLNNGCGC WANGTYHEAG SEFWADGTCS QWCRCGPGGG SLVCTPASCG LGEVCGLLPS GQHGCQPVST AECQAWGDPH YVTLDGHRFD FQGTCEYLLS APCHGPPLGA ENFTVTVANE HRGSQAVSYT RSVTLQIYNH SLTLSARWPR KLQVDGVFVT LPFQLDSLLH AHLSGADVVV TTTSGLSLAF DGDSFVRLRV PAAYAGSLCG LCGNYNQDPA DDLKAVGGKP AGWQVGGAQG CGECVSKPCP SPCTPEQQES FGGPDACGVI SATDGPLAPC HGLVPPAQYF QGCLLDACQV QGHPGGLCPA VATYVAACQA AGAQLREWRR PDFCPFQCPA HSHYELCGDS CPGSCPSLSA PEGCESACRE GCVCDAGFVL SGDTCVPVGQ CGCLHDDRYY PLGQTFYPGP GCDSLCRCRE GGEVSCEPSS CGPHETCRPS GGSLGCVAVG STTCQASGDP HYTTFDGHRF DFMGTCVYVL AQTCGTRPGL HRFAVLQENV AWGNGRVSVT RVITVQVANF TLRLEQRQWK VTVNGVDMKL PVVLANGQIR ASQHGSDVVI ETDFGLRVAY DLVYYVRVTV PGNYYQLMCG LCGNYNGDPK DDFQKPNGSQ AGNANEFGNS WEEVVPDSPC LPPPTCPPGS AGCIPSDKCP PELEKKYQKE EFCGLLSSPT GPLSSCHKLV DPQGPLKDCI FDLCLGGGNL SILCSNIHAY VSACQAAGGH VEPWRNETFC PMECPQNSHY ELCADTCSLG CSALSAPLQC PDGCAEGCQC DSGFLYNGQA CVPIQQCGCY HNGVYYEPEQ TVLIDNCRQQ CTCHVGKVVV CQEHSCKPGQ VCQPSGGILS CVTKDPCHGV TCRPQETCKE QGGQGVCLPN YEATCWLWGD PHYHSFDGRK FDFQGTCNYV LATTGCPGVS TQGLTPFTVT TKNQNRGNPA VSYVRVVTVA ALGTNISIHK DEIGKVRVNG VLTALPVSVA DGRISVAQGA SKALLVADFG LQVSYDWNWR VDVTLPSSYH GAVCGLCGNM DRNPNNDQVF PNGTLAPSIP IWGGSWRAPG WDPLCWDECR GSCPTCPEDR LEQYEGPGFC GPLSSGTGGP FTTCHAHVPP ESFFKGCVLD VCMGGGDRDI LCKALASYVA ACQAAGVVIE DWRAQVGCEI TCPENSHYEV CGPPCPASCP SPAPLTTPAV CEGPCVEGCQ CDAGFVLSAD RCVPLNNGCG CWANGTYHEA GSEFWADGTC SQWCRCGPGG GSLVCTPASC GLGEVCGLLP SGQHGCQPVS TAECQAWGDP HYVTLDGHRF DFQGTCEYLL SAPCHGPPLG AENFTVTVAN EHRGSQAVSY TRSVTLQIYN HSLTLSARWP RKLQVDGVFV ALPFQLDSLL HAHLSGADVV VTTTSGLSLA FDGDSFVRLR VPAAYAASLC GLCGNYNQDP ADDLKAVGGK PAGWQVGGAQ GCGECVSKPC PSPCTPEQQE SFGGPDACGV ISATDGPLAP CHGLVPPAQY FQGCLLDACQ VQGHPGGLCP AVATYVAACQ AAGAQLGEWR RPDFCPLQCP AHSHYELCGD SCPVSCPSLS APEGCESACR EGCVCDAGFV LSGDTCVPVG QCGCLHDGRY YPLGEVFYPG PECERRCECG PGGHVTCQEG AACGPHEECR LEDGVQACHA TGCGRCLANG GIHYITLDGR VYDLHGSCSY VLAQVCHPKP GDEDFSIVLE KNAAGDLQRL LVTVAGQVVS LAQGQQVTVD GEAVALPVAV GRVRVTAEGR NMVLQTTKGL RLLFDGDAHL LMSIPSPFRG RLCGLCGNFN GNWSDDFVLP NGSAASSVET FGAAWRAPGS SKGCGEGCGP QGCPVCLAEE TAPYESNEAC GQLRNPQGPF ATCQAVLSPS EYFRQCVYDL CAQKGDKAFL CRSLAAYTAA CQAAGVAVKP WRTDSFCPLH CPAHSHYSIC TRTCQGSCAA LSGLTGCTTR CFEGCECDDR FLLSQGVCIP VQDCGCTHNG RYLPVNSSLL TSDCSERCSC SSSSGLTCQA AGCPPGRVCE VKAEARNCWA TRGLCVLSVG ANLTTFDGAR GATTSPGVYE LSSRCPGLQN TIPWYRVVAE VQICHGKTEA VGQVHIFFQD GMVTLTPNKG VWVNGLRVDL PAEKLASVSV SRTPDGSLLV RQKAGVQVWL GANGKVAVIV SNDHAGKLCG ACGNFDGDQT NDWHDSQEKP AMEKWRAQDF SPCYG //